| Literature DB >> 32015796 |
Jie Yang1, Lingchuan Song1, Xiaoyi Yao2, Qian Cheng1, Zichao Cheng3, Ke Xu1.
Abstract
Private sector participation in the healthcare market via public-private partnership (PPP) could be considered an available approach to narrow down the medical resource gap and improve the operational efficiency of healthcare facilities. Accordingly, this study aims to examine the influence and relative importance among critical factors for the intention and behaviour of the private sector towards participation in Chinese healthcare market (CHM) via PPP. We defined five hypotheses from previous literature and built a theoretical model based on modified theory of planned behaviour. Then, covariance-based structural equation modelling was applied to analyse the questionnaires provided by 248 respondents from construction companies, real estate developers, pharmaceutical companies, private hospitals, asset management companies, and medical industry property investment companies in China. Results indicated that attitude towards behaviour (β = 0.466, P < 0.001), subjective norm (β = 0.167, P < 0.05), perceived behavioural control (β = 0.231, P < 0.01), and facilitating conditions (β = 0.305, P < 0.001) are positively significant to behavioural intention; behavioural intention also shows a strong linkage with behaviour (β = 0.931, P < 0.001). Findings provide reference for governments and public authorities to exert additional efforts in implementing appropriate measures that will stimulate the private sector's motivation to participate in CHM via PPP.Entities:
Mesh:
Year: 2020 PMID: 32015796 PMCID: PMC6988663 DOI: 10.1155/2020/5834532
Source DB: PubMed Journal: J Healthc Eng ISSN: 2040-2295 Impact factor: 2.682
Representative types for private sector investment in CHM via PPP.
| Types of PPP in the healthcare field | Features | Categories of private sector | Empirical examples |
|---|---|---|---|
| BOT | This type has the widest scope of contract. In practice, the partnership concentrates on the construction of healthcare services without depth in management and operational stages. | (1) Construction companies | (1) Jinan Zhangqiu North Medical Comprehensive Service Center |
|
| |||
| TOT | This type is generally applied in existing medical services. Private sector undertakes all business management aspects (drug and medical equipment supply, supermarket, canteen, and property), except core medical care (clinical work). | (1) Pharmaceutical companies | (1) Tongliao Zhongmeng Hospital |
|
| |||
| ROT | This type is also known as invest-operate-transfer (IOT). Private sector rebuilds and upgrades several equipment based on TOT. | (1) Medical industry property investment companies | (1) Shenyang Fifth People's Hospital |
|
| |||
| O&M | Governments remain the owner of public hospital and outsource nonclinical work (daily operation and management) to the private sector. | (1) Private hospitals | (1) Beijing Mentougou Hospital |
Figure 1Structural model based on the modified TPB.
Survey items and certain indices.
| Variables and survey items | Cronbach's | AVE | Literature |
|---|---|---|---|
| AB: | |||
| AB1: I could obtain potential opportunities of investment by participating in CHM. | 0.909 | 0.719 | [ |
| AB2: Participating in CHM could increase operational benefits. | |||
| AB3: Participating in CHM could obtain external political privileges. | |||
| AB4: I can strengthen the competitiveness of nonclinical (or clinical) work by establishing partnership with public authorities. | |||
|
| |||
| SN: | |||
| SN1: Participating in Chinese healthcare service delivery could earn additional social reputation. | 0.817 | 0.537 | [ |
| SN2: An increasing number of my competitors is involved in CHM. | |||
| SN3: Investing in CHM helps me win recognition from public authorities. | |||
| SN4: Investing in CHM helps me earn prestige from my competitors. | |||
|
| |||
| PBC: | |||
| PBC1: The barriers to enter CHM is acceptable for me. | 0.885 | 0.722 | [ |
| PBC2: I could gain requisite knowledge and capital to invest in Chinese medical service delivery if I am willing. | |||
| PBC3: Given the necessary resources and knowledge, involvement in CHM would be easy for me. | |||
|
| |||
| FC: | |||
| FC1: Public authorities encourage private investors to participate in CHM. | 0.899 | 0.735 | [ |
| FC2: Supportive polices with potential benefits have been issued to make an easy approach for private capital investment in CHM. | |||
| FC3: Official guidance is available to me to establish partnership with public authorities and invest in CHM. | |||
| FC4: Employees in my company have received necessary training towards participating in Chinese healthcare service delivery. | |||
|
| |||
| BI: | |||
| BI1: I am willing to try to participate in CHM step by step. | 0.865 | 0.607 | [ |
| BI2: Investing in CHM by PPP rather than other fields or full privatisation is a good idea. | |||
| BI3: Personnel in my company would be glad to accept related training. | |||
| BI4: CHM would be one of my favourite fields to invest by PPP. | |||
|
| |||
| B: | |||
| B1: I have engaged in Chinese healthcare resources supply via PPP. | 0.847 | 0.649 | [ |
| B2: I suggested other partners to also participate in CHM via PPP. | |||
| B3: I will keep partnering with public authorities and investing in CHM. | |||
Sample demographics.
| Type | Frequency | Percentage (%) | |
|---|---|---|---|
| Gender | Male | 166 | 66.9 |
| Female | 82 | 33.1 | |
|
| |||
| Working experience | 3–5 years | 53 | 21.4 |
| 6–10 years | 122 | 49.2 | |
| 11–15 years | 31 | 12.5 | |
| 16–20 years | 29 | 11.7 | |
| More than 20 years | 13 | 5.2 | |
|
| |||
| Occupation | Construction companies | 64 | 25.8 |
| Real estate developers | 53 | 21.4 | |
| Pharmaceutical companies | 27 | 10.9 | |
| Private hospitals | 39 | 15.7 | |
| Asset management companies | 41 | 16.5 | |
| Medical industry property investment companies | 24 | 9.7 | |
|
| |||
| Position | Administrative staff | 173 | 69.8 |
| Basic staff | 75 | 30.2 | |
Goodness-of-fit test measure.
| Goodness-of-fit measure | Acceptable threshold | Value of model | Evaluation |
|---|---|---|---|
| CMIN/DF | <3.00 | 2.005 | √ |
| GFI | >0.90 | 0.906 | √ |
| AGFI | >0.90 | 0.886 | √ |
| RFI | >0.90 | 0.911 | √ |
| NFI | >0.90 | 0.936 | √ |
| CFI | >0.90 | 0.950 | √ |
| RMSEA | <0.08 | 0.064 | √ |
| PNFI | >0.50 | 0.777 | √ |
| PCFI | >0.50 | 0.815 | √ |
| PGFI | >0.50 | 0.686 | √ |
CR value of latent variables.
| Latent variables | Composite reliability value |
|---|---|
| AB | 0.911 |
| FC | 0.917 |
| SN | 0.820 |
| PBC | 0.886 |
| BI | 0.861 |
| B | 0.847 |
Figure 2Structural model with path coefficients (β) and factor loading (a).
Hypothesis assessments.
| Hypothesis | Path |
| CR ( |
| Result |
|---|---|---|---|---|---|
| H1 | BI ⟵ AB | 0.466 | 8.712 |
| Supported |
| H2 | BI ⟵ FC | 0.305 | 5.999 |
| Supported |
| H3 | BI ⟵ SN | 0.167 | 2.466 |
| Supported |
| H4 | BI ⟵ PBC | 0.231 | 3.136 |
| Supported |
| H5 | B ⟵ BI | 0.931 | 12.588 |
| Supported |
P < 0.001; P < 0.01; P < 0.05.